Both in Pharmaceuticals
Ovid Therapeutics vs CytomX Therapeutics
Over the past year OVID returned +106.0% and CTMX returned −42.5%; their daily moves had a correlation of 0.23.
OVID +106.0% CTMX −42.5%Growth of $1, one year, split-adjusted
| Metric | OVID | CTMX |
|---|---|---|
| Price | $2.51 | $2.28 |
| Market cap | $490.2M | $496.8M |
| Today | +4.58% | +4.59% |
| 1 month | +5.9% | −10.9% |
| 6 months | −9.7% | −44.8% |
| Year to date | +54.0% | −46.5% |
| 1 year | +81.9% | −42.0% |
| Revenue growth (YoY) | −88.3% | −92.4% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −2047.6% | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | 309.7× | 27.1× |
| Net cash | $117.2M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 59.7% | 68.4% |
| Short % of float | 10.2% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).